AAAAAA

   
Results: 1-8 |
Results: 8
HEMODYNAMIC DIFFERENCES BETWEEN METOPROLOL AND CARVEDILOL IN HYPERTENSIVE PATIENTS
Authors: WEBER K BOHMEKE T VANDERDOES R TAYLOR SH
Citation: K. Weber et al., HEMODYNAMIC DIFFERENCES BETWEEN METOPROLOL AND CARVEDILOL IN HYPERTENSIVE PATIENTS, American journal of hypertension, 11(5), 1998, pp. 614-617
CARVEDILOL IN COMPARISON AND IN COMBINATION WITH ISOSORBIDE DINITRATESUSTAINED-RELEASE IN PATIENTS WITH CHRONIC STABLE EFFORT-INDUCED ANGINA-PECTORIS
Authors: HAUFZACHARIOU U PFARR E VANDERDOES R
Citation: U. Haufzachariou et al., CARVEDILOL IN COMPARISON AND IN COMBINATION WITH ISOSORBIDE DINITRATESUSTAINED-RELEASE IN PATIENTS WITH CHRONIC STABLE EFFORT-INDUCED ANGINA-PECTORIS, Clinical drug investigation, 14(6), 1997, pp. 465-473
BENEFICIAL-EFFECTS OF INTRAVENOUS AND ORAL CARVEDILOL TREATMENT IN ACUTE MYOCARDIAL-INFARCTION - A PLACEBO-CONTROLLED, RANDOMIZED TRIAL
Authors: BASU S SENIOR R RAVAL U VANDERDOES R BRUCKNER T LAHIRI A
Citation: S. Basu et al., BENEFICIAL-EFFECTS OF INTRAVENOUS AND ORAL CARVEDILOL TREATMENT IN ACUTE MYOCARDIAL-INFARCTION - A PLACEBO-CONTROLLED, RANDOMIZED TRIAL, Circulation, 96(1), 1997, pp. 183-191
COMPARISON OF THE HEMODYNAMIC-EFFECTS OF METOPROLOL AND CARVEDILOL INHYPERTENSIVE PATIENTS
Authors: WEBER K BOHMEKE T VANDERDOES R TAYLOR SH
Citation: K. Weber et al., COMPARISON OF THE HEMODYNAMIC-EFFECTS OF METOPROLOL AND CARVEDILOL INHYPERTENSIVE PATIENTS, Cardiovascular drugs and therapy, 10(2), 1996, pp. 113-117
SAFETY PROFILE OF EARLY TREATMENT WITH VASODILATING BETA-BLOCKER CARVEDILOL FOLLOWING ACUTE MYOCARDIAL-INFARCTION
Authors: BASU S KINSEY C VANDERDOES R LAHIRI A
Citation: S. Basu et al., SAFETY PROFILE OF EARLY TREATMENT WITH VASODILATING BETA-BLOCKER CARVEDILOL FOLLOWING ACUTE MYOCARDIAL-INFARCTION, Circulation, 94(8), 1996, pp. 519-519
LONG-TERM SAFETY OF HIGH-DOSE ORAL TREATMENT WITH THE NEW LOOP DIURETIC TORASEMIDE IN PATIENTS WITH ADVANCED CHRONIC-RENAL-FAILURE
Authors: BOESKEN W KULT J KUHN A MEYERSABELLEK W PIESCHE L VANDERDOES R
Citation: W. Boesken et al., LONG-TERM SAFETY OF HIGH-DOSE ORAL TREATMENT WITH THE NEW LOOP DIURETIC TORASEMIDE IN PATIENTS WITH ADVANCED CHRONIC-RENAL-FAILURE, Kidney international, 47(3), 1995, pp. 992-992
CARVEDILOL REDUCES ADVERSE CARDIAC EVENTS FOLLOWING ACUTE MYOCARDIAL-INFARCTION
Authors: BASU S SENIOR R VANDERDOES R KINSEY C BRUCKNER T RAFTERY EB LAHIRI A
Citation: S. Basu et al., CARVEDILOL REDUCES ADVERSE CARDIAC EVENTS FOLLOWING ACUTE MYOCARDIAL-INFARCTION, Circulation, 92(8), 1995, pp. 91-91
ANTIHYPERTENSIVE THERAPY WITH THE VASODIL ATING BETA-BLOCKER CARVEDILOL - COMPARISON OF ACUTE AND SUBCHRONIC CARDIOVASCULAR EFFECTS WITH METOPROLOL
Authors: BOHMEKE T WEBER K VANDERDOES R NOCKER B RICKEN D
Citation: T. Bohmeke et al., ANTIHYPERTENSIVE THERAPY WITH THE VASODIL ATING BETA-BLOCKER CARVEDILOL - COMPARISON OF ACUTE AND SUBCHRONIC CARDIOVASCULAR EFFECTS WITH METOPROLOL, Herz, Kreislauf, 26(1), 1994, pp. 22-26
Risultati: 1-8 |